{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:35:30Z","timestamp":1793118930417,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":2480,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1074\/jbc.m113.503813","type":"journal-article","created":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T22:55:53Z","timestamp":1383605753000},"page":"36554-36566","source":"Crossref","is-referenced-by-count":132,"title":["Targeted Deletion of Kynurenine 3-Monooxygenase in Mice"],"prefix":"10.1016","volume":"288","author":[{"given":"Flaviano","family":"Giorgini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korrapati V.","family":"Sathyasaikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian A.R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Tararina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Muchowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.503813_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/187152710793237430","article-title":"Targeting kynurenine 3-monooxygenase (KMO). Implications for therapy in Huntington's disease","volume":"9","author":"Thevandavakkam","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1074\/jbc.M113.503813_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ajcn\/24.6.659","article-title":"Quantitative aspects of tryptophan metabolism in humans and other species. A review","volume":"24","author":"Leklem","year":"1971","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1074\/jbc.M113.503813_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/bj2830633","article-title":"Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid","volume":"283","author":"Heyes","year":"1992","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M113.503813_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0021-9258(18)70659-5","article-title":"The intermediary metabolism of tryptophan by cat and rat tissue preparations","volume":"228","author":"De Castro","year":"1957","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.503813_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes. A paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib6","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","article-title":"Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment","volume":"283","author":"Giorgini","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.503813_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4613-0381-7_28","article-title":"Regulation of the kynurenine pathway by IFN-\u03b3 in murine cloned macrophages and microglial cells","volume":"398","author":"Alberati-Giani","year":"1996","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1074\/jbc.M113.503813_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2008.06.007","article-title":"Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge. A role for IFN-\u03b3?","volume":"441","author":"Connor","year":"2008","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M113.503813_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.503813_bib10","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.503813_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.2092","article-title":"Kynurenine is an endothelium-derived relaxing factor produced during inflammation","volume":"16","author":"Wang","year":"2010","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M113.503813_bib12","doi-asserted-by":"crossref","first-page":"e19823","DOI":"10.1371\/journal.pone.0019823","article-title":"The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-d-tryptophan upregulates IDO1 in human cancer cells","volume":"6","author":"Opitz","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.503813_bib13","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M113.503813_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0003-9861(92)90733-D","article-title":"Formation of hydroxanthommatin-derived radical in the oxidation of 3-hydroxykynurenine","volume":"294","author":"Ishii","year":"1992","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.M113.503813_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/carcin\/16.2.349","article-title":"Metal-mediated oxidative damage to cellular and isolated DNA by certain tryptophan metabolites","volume":"16","author":"Hiraku","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1074\/jbc.M113.503813_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","article-title":"3-Hydroxykynurenine. An intriguing molecule exerting dual actions in the central nervous system","volume":"34","author":"Col\u00edn-Gonz\u00e1lez","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1074\/jbc.M113.503813_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1258\/0004563011900461","article-title":"3-Hydroxyanthranilic acid, an l-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-\u03b3","volume":"38","author":"Morita","year":"2001","journal-title":"Ann. Clin. Biochem"},{"key":"10.1074\/jbc.M113.503813_bib18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem. Res"},{"key":"10.1074\/jbc.M113.503813_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid. A potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol"},{"key":"10.1074\/jbc.M113.503813_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain. When physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1074\/jbc.M113.503813_bib21","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits \u03b17 nicotinic receptor activity and increases non-\u03b17 nicotinic receptor expression. Physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M113.503813_bib22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A glycine site associated with N-methyl-d-aspartic acid receptors. Characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib23","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.503813_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol. Sci"},{"key":"10.1074\/jbc.M113.503813_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid. Free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitr\u00f3n","year":"2011","journal-title":"Neurotoxicol. Teratol"},{"key":"10.1074\/jbc.M113.503813_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M113.503813_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(88)90813-0","article-title":"The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection","volume":"90","author":"Andin\u00e9","year":"1988","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M113.503813_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00702-011-0763-x","article-title":"Kynurenic acid. A metabolite with multiple actions and multiple targets in brain and periphery","volume":"119","author":"Moroni","year":"2012","journal-title":"J. Neural Transm"},{"key":"10.1074\/jbc.M113.503813_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/14728220802665734","article-title":"New promises for manipulation of kynurenine pathway in cancer and neurological diseases","volume":"13","author":"Costantino","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/jbc.M113.503813_bib30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.503813_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbq002","article-title":"Cortical kynurenine pathway metabolism. A novel target for cognitive enhancement in schizophrenia","volume":"36","author":"Wonodi","year":"2010","journal-title":"Schizophr. Bull"},{"key":"10.1074\/jbc.M113.503813_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Curr. Biol"},{"key":"10.1074\/jbc.M113.503813_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0306-4522(94)90227-5","article-title":"Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities","volume":"61","author":"Carpenedo","year":"1994","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.M113.503813_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(96)00613-9","article-title":"(RS)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats","volume":"315","author":"Speciale","year":"1996","journal-title":"Eur. J. Pharmacol"},{"key":"10.1074\/jbc.M113.503813_bib35","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/jm970467t","article-title":"Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase","volume":"40","author":"R\u00f6ver","year":"1997","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.503813_bib36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1471-4159.2009.05893.x","article-title":"On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo","volume":"109","author":"Amori","year":"2009","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12039","article-title":"Structural basis of kynurenine 3-monooxygenase inhibition","volume":"496","author":"Amaral","year":"2013","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.503813_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng0298-136","article-title":"An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination","volume":"18","author":"Meyers","year":"1998","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M113.503813_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/75973","article-title":"High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP","volume":"25","author":"Rodr\u00edguez","year":"2000","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M113.503813_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1101\/SQB.1997.062.01.021","article-title":"Analysis of Fgf8 gene function in vertebrate development","volume":"62","author":"Lewandoski","year":"1997","journal-title":"Cold Spring Harb. Symp. Quant. Biol"},{"key":"10.1074\/jbc.M113.503813_bib41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0378-4347(00)83925-0","article-title":"Quantification of 3-hydroxykynurenine in brain by high-performance liquid chromatography and electrochemical detection","volume":"428","author":"Heyes","year":"1988","journal-title":"J. Chromatogr"},{"key":"10.1074\/jbc.M113.503813_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.1986.tb02826.x","article-title":"Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro","volume":"47","author":"Foster","year":"1986","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.1985.tb05435.x","article-title":"Quinolinic acid phosphoribosyltransferase in rat brain","volume":"44","author":"Foster","year":"1985","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1010960812204","article-title":"Changes in kynurenic, anthranilic, and quinolinic acid concentrations in rat brain tissue during development","volume":"26","author":"Cannazza","year":"2001","journal-title":"Neurochem. Res"},{"key":"10.1074\/jbc.M113.503813_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ab.2011.12.032","article-title":"Gas chromatography\/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain","volume":"421","author":"Notarangelo","year":"2012","journal-title":"Anal. Biochem"},{"key":"10.1074\/jbc.M113.503813_bib46","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1471-4159.2005.03134.x","article-title":"Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum","volume":"93","author":"Rassoulpour","year":"2005","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","article-title":"Human microglia convert l-tryptophan into the neurotoxin quinolinic acid","volume":"320","author":"Heyes","year":"1996","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M113.503813_bib48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1471-4159.1990.tb04553.x","article-title":"Presence of 3-hydroxyanthranilic acid in rat tissues and evidence for its production from anthranilic acid in the brain","volume":"55","author":"Baran","year":"1990","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib49","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3945\/jn.113.176875","article-title":"The niacin required for optimum growth can be synthesized from l-tryptophan in growing mice lacking tryptophan-2,3-dioxygenase","volume":"143","author":"Terakata","year":"2013","journal-title":"J. Nutr"},{"key":"10.1074\/jbc.M113.503813_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","article-title":"NAD+ metabolism in health and disease","volume":"32","author":"Belenky","year":"2007","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.M113.503813_bib51","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3945\/jn.112.167569","article-title":"Establishment of true niacin deficiency in quinolinic acid phosphoribosyltransferase knockout mice","volume":"142","author":"Terakata","year":"2012","journal-title":"J. Nutr"},{"key":"10.1074\/jbc.M113.503813_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1074\/jbc.M113.503813_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"M\u00e1ndi","year":"2012","journal-title":"J. Neural Transm"},{"key":"10.1074\/jbc.M113.503813_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00331364","article-title":"Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system","volume":"278","author":"Moffett","year":"1994","journal-title":"Cell Tissue Res"},{"key":"10.1074\/jbc.M113.503813_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1734-1140(09)70130-6","article-title":"Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells","volume":"61","author":"Wejksza","year":"2009","journal-title":"Pharmacol. Rep"},{"key":"10.1074\/jbc.M113.503813_bib56","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.npp.1300188","article-title":"Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat","volume":"28","author":"Shepard","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1074\/jbc.M113.503813_bib57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2004.06.006","article-title":"Endogenous kynurenic acid disrupts prepulse inhibition","volume":"56","author":"Erhardt","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1074\/jbc.M113.503813_bib58","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/schbul\/sbl033","article-title":"Elevations of endogenous kynurenic acid produce spatial working memory deficits","volume":"33","author":"Chess","year":"2007","journal-title":"Schizophr. Bull"},{"key":"10.1074\/jbc.M113.503813_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbr.2009.03.013","article-title":"l-Kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning","volume":"201","author":"Chess","year":"2009","journal-title":"Behav. Brain Res"},{"key":"10.1074\/jbc.M113.503813_bib60","first-page":"663.29","article-title":"Behavioral abnormalities in mice deficient in kynurenine 3-monooxygenase. Relevance to schizophrenia","volume":"37","author":"Thomas","year":"2012","journal-title":"Soc. Neurosci. Abstr"},{"key":"10.1074\/jbc.M113.503813_bib61","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2174\/092986711795656072","article-title":"Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases","volume":"18","author":"Prendergast","year":"2011","journal-title":"Curr. Med. Chem"},{"key":"10.1074\/jbc.M113.503813_bib62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00702-011-0658-x","article-title":"Kynurenines and intestinal neurotransmission. The role of N-methyl-d-aspartate receptors","volume":"119","author":"Kaszaki","year":"2012","journal-title":"J. Neural Transm"},{"key":"10.1074\/jbc.M113.503813_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00702-010-0475-7","article-title":"Interferon-\u03b3-inducible kynurenines\/pteridines inflammation cascade. Implications for aging and aging-associated psychiatric and medical disorders","volume":"118","author":"Oxenkrug","year":"2011","journal-title":"J. Neural Transm"},{"key":"10.1074\/jbc.M113.503813_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(92)90214-6","article-title":"Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and \u03b22-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients","volume":"40","author":"Heyes","year":"1992","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/jbc.M113.503813_bib65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature06471","article-title":"Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease","volume":"451","author":"Romani","year":"2008","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.503813_bib66","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004647-199907000-00007","article-title":"Kynurenine hydroxylase inhibitors reduce ischemic brain damage. Studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia","volume":"19","author":"Cozzi","year":"1999","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1074\/jbc.M113.503813_bib67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS. Recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.M113.503813_bib68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00702-011-0676-8","article-title":"Involvement of kynurenines in Huntington's disease and stroke-induced brain damage","volume":"119","author":"Stone","year":"2012","journal-title":"J. Neural. Transm"},{"key":"10.1074\/jbc.M113.503813_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans. Disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan. Res"},{"key":"10.1074\/jbc.M113.503813_bib70","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archgenpsychiatry.2011.71","article-title":"Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes","volume":"68","author":"Wonodi","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1074\/jbc.M113.503813_bib71","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull"},{"key":"10.1074\/jbc.M113.503813_bib72","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.neuint.2008.01.013","article-title":"Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder","volume":"52","author":"Miller","year":"2008","journal-title":"Neurochem. Int"},{"key":"10.1074\/jbc.M113.503813_bib73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1074\/jbc.M113.503813_bib74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF03033242","article-title":"Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission","volume":"10","author":"M\u00fcller","year":"2006","journal-title":"Neurotox. Res"},{"key":"10.1074\/jbc.M113.503813_bib75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.physbeh.2007.05.025","article-title":"The kynurenic acid hypothesis of schizophrenia","volume":"92","author":"Erhardt","year":"2007","journal-title":"Physiol. Behav"},{"key":"10.1074\/jbc.M113.503813_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1503\/jpn.100175","article-title":"Kynurenine 3-monooxygenase polymorphisms. Relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls","volume":"37","author":"Holtze","year":"2012","journal-title":"J. Psychiatry Neurosci"},{"key":"10.1074\/jbc.M113.503813_bib77","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.M113.503813_bib78","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.M113.503813_bib79","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1046\/j.1471-4159.1995.65031176.x","article-title":"Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and\/or kynureninase","volume":"65","author":"Chiarugi","year":"1995","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.503813_bib80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbr.2007.08.007","article-title":"Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys","volume":"186","author":"Gr\u00e9goire","year":"2008","journal-title":"Behav. Brain Res"},{"key":"10.1074\/jbc.M113.503813_bib81","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat. Genet"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820553490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820553490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.503813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T20:49:49Z","timestamp":1641329389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820553490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":81,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0021925820553490"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.503813","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}